(Q24198916)

21 October 2023

Ning Chen

2

Ning

Chen

1 reference

21 October 2023

Li He

3

Li

He

1 reference

21 October 2023

Mi Yang

4

Mi

Yang

1 reference

21 October 2023

Cairong Zhu

5

Cairong

Zhu

1 reference

21 October 2023

Fengbo Wu

6

Fengbo

Wu

1 reference

Cochrane Database of Systematic Reviews

21 October 2023

publication date

28 March 2013

0 references

published in

0 references

cites work

Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Phenytoin for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Assessment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Molecular aspects of pain research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Rationale and Evidence for the Use of Oxcarbazepine in Neuropathic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Clonazepam for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Epidemiology of cancer pain and factors influencing poor pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Neurobiology of neuropathic pain: mode of action of anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Antiepileptic drugs in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Chronic neuropathic pain: mechanisms, drug targets and measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Opioids and chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Lumbar disc syndrome in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

The clinical picture of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Anticonvulsants in neuropathic pain: rationale and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Gabapentin for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Oxcarbazepine in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Bad news from the brain: descending 5-HT pathways that control spinal pain processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

HIV-associated neuropathic pain: epidemiology, pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Neuropathic pain after traumatic spinal cord injury--relations to gender, spinal level, completeness, and age at the time of injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Anticonvulsant drugs for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Lamotrigine for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Carbamazepine for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Pain: a review of three commonly used pain rating scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

Oxcarbazepine for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007963.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD007963.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3883083

Fatcat ID

release_addowsi5yfaofdu2auv3f7lumy

0 references

OpenCitations bibliographic resource ID

3883083

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3883083